Thus, exacerbated SARS-CoV-2 replication in respiratory tissues alone may not fully explain the contributions of anti-IFN autoantibodies to severe COVID-19 and other systemic pathogenic mechanisms may occur. The gene discussed is IFNA1; the disease is COVID-19.